{"transactions":[{"id":730165,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":36264,"kind":"person","name":"Carter Eric G","position":1,"cik":"0001387660","reported_name":"Carter Eric G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-22T22:16:10.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":222684,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\") granted on June 17, 2026 (the \"Grant Date\").  The RSUs vest in full on the earlier to occur of (i) the one (1) year anniversary of the Grant Date and (ii) the date of the 2027 annual meeting of the Company's stockholders, subject to continued service through the applicable vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\") granted on June 17, 2026 (the \"Grant Date\").  The RSUs vest in full on the earlier to occur of (i) the one (1) year anniversary of the Grant Date and (ii) the date of the 2027 annual meeting of the Company's stockholders, subject to continued service through the applicable vesting date."}],"balance_after":258705,"source":{"system":"sec-edgar","filing":"0001104659-26-076509","document":"tm2618486-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1387660/000110465926076509/tm2618486-1_4seq1.xml","form_type":"4"}},{"id":1134860,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":36264,"kind":"person","name":"Carter Eric G","position":1,"cik":"0001387660","reported_name":"Carter Eric G","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2025-05-23T20:50:53.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":308641,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") will be settled in cash based on the fair market value of the Issuer's Class A Common Stock on the applicable vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the RSUs shall vest in full on the one year anniversary of May 21, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"100% of the RSUs shall vest in full on the one year anniversary of May 21, 2025."}],"balance_after":308641,"derivative":{"underlying":"Class A Common Stock","underlying_shares":308641},"source":{"system":"sec-edgar","filing":"0001610717-25-000131","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1387660/000161071725000131/form4.xml","form_type":"4"}},{"id":1415331,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":36264,"kind":"person","name":"Carter Eric G","position":1,"cik":"0001387660","reported_name":"Carter Eric G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-09-05T01:52:57.000Z","date":"2024-08-31","kind":"grant","planned":false,"acquired":true,"shares":96210,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents an award of stock options granted on August 31, 2024 (the \"Grant Date\"), which vest and become exercisable in substantially equal monthly installments over the eighteen months following the Grant Date, subject to the reporting person's continued service through the applicable vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents an award of stock options granted on August 31, 2024 (the \"Grant Date\"), which vest and become exercisable in substantially equal monthly installments over the eighteen months following the Grant Date, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":96210,"derivative":{"exercise_price":0.83,"expiration_date":"2034-08-30","underlying":"Class A Common Stock","underlying_shares":96210},"source":{"system":"sec-edgar","filing":"0001104659-24-097061","document":"tm2423415-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1387660/000110465924097061/tm2423415-1_4seq1.xml","form_type":"4"}},{"id":1415330,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":36264,"kind":"person","name":"Carter Eric G","position":1,"cik":"0001387660","reported_name":"Carter Eric G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-09-05T01:52:57.000Z","date":"2024-08-31","kind":"grant","planned":false,"acquired":true,"shares":36021,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of restricted stock units granted on August 31, 2024 (the \"Grant Date\"), which vests in full on the second anniversary of the Grant Date, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":36021,"source":{"system":"sec-edgar","filing":"0001104659-24-097061","document":"tm2423415-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1387660/000110465924097061/tm2423415-1_4seq1.xml","form_type":"4"}},{"id":1564612,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":36264,"kind":"person","name":"Carter Eric G","position":1,"cik":"0001387660","reported_name":"Carter Eric G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-03-21T23:45:20.000Z","date":"2024-03-19","kind":"grant","planned":false,"acquired":true,"shares":8130,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of stock options granted on March 19, 2024 (the \"Grant Date\"), which vests in substantially equal monthly installments over the one year following the Grant Date, subject to the reporting person's continued service through the applicable vesting date.  Option will vest in full upon a Change in Control (as defined in the AEON Biopharma Inc. 2023 Incentive Award Plan) of the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents an award of stock options granted on March 19, 2024 (the \"Grant Date\"), which vests in substantially equal installments on each of the first, second, third and fourth anniversary of the Grant Date, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":8130,"derivative":{"exercise_price":14.4,"expiration_date":"2034-03-18","underlying":"Common Stock","underlying_shares":8130},"source":{"system":"sec-edgar","filing":"0001104659-24-037434","document":"tm249503-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1387660/000110465924037434/tm249503-2_4seq1.xml","form_type":"4"}},{"id":1564611,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":36264,"kind":"person","name":"Carter Eric G","position":1,"cik":"0001387660","reported_name":"Carter Eric G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-03-21T23:45:20.000Z","date":"2024-03-19","kind":"grant","planned":false,"acquired":true,"shares":16260,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of stock options granted on March 19, 2024 (the \"Grant Date\"), which vests in substantially equal monthly installments over the one year following the Grant Date, subject to the reporting person's continued service through the applicable vesting date.  Option will vest in full upon a Change in Control (as defined in the AEON Biopharma Inc. 2023 Incentive Award Plan) of the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an award of stock options granted on March 19, 2024 (the \"Grant Date\"), which vests in substantially equal monthly installments over the one year following the Grant Date, subject to the reporting person's continued service through the applicable vesting date.  Option will vest in full upon a Change in Control (as defined in the AEON Biopharma Inc. 2023 Incentive Award Plan) of the Company."}],"balance_after":16260,"derivative":{"exercise_price":14.4,"expiration_date":"2034-03-18","underlying":"Common Stock","underlying_shares":16260},"source":{"system":"sec-edgar","filing":"0001104659-24-037434","document":"tm249503-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1387660/000110465924037434/tm249503-2_4seq1.xml","form_type":"4"}},{"id":1805268,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":36264,"kind":"person","name":"Carter Eric G","position":1,"cik":"0001387660","reported_name":"Carter Eric G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-08-16T20:05:23.000Z","date":"2023-08-14","kind":"grant","planned":false,"acquired":true,"shares":58851,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of stock options on August 14, 2023, which vests in three yearly installments from August 14, 2023, subject to the reporting person's continued service through the applicable vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an award of stock options on August 14, 2023, which vests in three yearly installments from August 14, 2023, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":58851,"derivative":{"exercise_price":5.47,"expiration_date":"2033-08-13","underlying":"Common Stock","underlying_shares":58851},"source":{"system":"sec-edgar","filing":"0001104659-23-092542","document":"tm2323956-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1387660/000110465923092542/tm2323956-1_4seq1.xml","form_type":"4"}},{"id":1824068,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":36264,"kind":"person","name":"Carter Eric G","position":1,"cik":"0001387660","reported_name":"Carter Eric G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-07-25T01:09:47.000Z","date":"2023-07-21","kind":"grant","planned":false,"acquired":true,"shares":11802,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 21, 2023, pursuant to that certain Business Combination Agreement, dated as of December 12, 2022, as amended April 27, 2023, by and among the Issuer, Priveterra Merger Sub, Inc. (\"Merger Sub\") and AEON Biopharma, Inc. (\"AEON\"), upon consummation of the transactions contemplated thereby (the \"Effective Time\"), each issued and outstanding share of common stock of AEON (\"AEON common stock\") was automatically cancelled and converted into approximately 2.328 (the \"Exchange Ratio\") shares of Class A common stock of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"At the Effective Time, each outstanding option to purchase shares of AEON common stock (each an \"AEON Option\") was automatically cancelled and converted into an option to purchase a number of shares of common stock of the Issuer equal to (i) the number of shares of AEON common stock subject to the applicable AEON Option multipled by (ii) the Exchange Ratio, rounded down to the nearest whole share."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents an award of stock options on October 5, 2022, which vests in two yearly installments from October 5, 2022, subject to the reporting person's continued service through the applicable vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 21, 2023, pursuant to that certain Business Combination Agreement, dated as of December 12, 2022, as amended April 27, 2023, by and among the Issuer, Priveterra Merger Sub, Inc. (\"Merger Sub\") and AEON Biopharma, Inc. (\"AEON\"), upon consummation of the transactions contemplated thereby (the \"Effective Time\"), each issued and outstanding share of common stock of AEON (\"AEON common stock\") was automatically cancelled and converted into approximately 2.328 (the \"Exchange Ratio\") shares of Class A common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents an award of stock options on October 5, 2022, which vests in two yearly installments from October 5, 2022, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":11802,"derivative":{"exercise_price":10,"expiration_date":"2032-10-05","underlying":"Common Stock","underlying_shares":11802},"source":{"system":"sec-edgar","filing":"0001104659-23-083568","document":"tm2321918-11_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1387660/000110465923083568/tm2321918-11_4seq1.xml","form_type":"4"}},{"id":1824067,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":36264,"kind":"person","name":"Carter Eric G","position":1,"cik":"0001387660","reported_name":"Carter Eric G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-07-25T01:09:47.000Z","date":"2023-07-21","kind":"grant","planned":false,"acquired":true,"shares":9007,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 21, 2023, pursuant to that certain Business Combination Agreement, dated as of December 12, 2022, as amended April 27, 2023, by and among the Issuer, Priveterra Merger Sub, Inc. (\"Merger Sub\") and AEON Biopharma, Inc. (\"AEON\"), upon consummation of the transactions contemplated thereby (the \"Effective Time\"), each issued and outstanding share of common stock of AEON (\"AEON common stock\") was automatically cancelled and converted into approximately 2.328 (the \"Exchange Ratio\") shares of Class A common stock of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"At the Effective Time, each outstanding option to purchase shares of AEON common stock (each an \"AEON Option\") was automatically cancelled and converted into an option to purchase a number of shares of common stock of the Issuer equal to (i) the number of shares of AEON common stock subject to the applicable AEON Option multipled by (ii) the Exchange Ratio, rounded down to the nearest whole share."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents an award of stock options on September 9, 2021, which vests in four yearly installments from March 9, 2021, subject to the reporting person's continued service through the applicable vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 21, 2023, pursuant to that certain Business Combination Agreement, dated as of December 12, 2022, as amended April 27, 2023, by and among the Issuer, Priveterra Merger Sub, Inc. (\"Merger Sub\") and AEON Biopharma, Inc. (\"AEON\"), upon consummation of the transactions contemplated thereby (the \"Effective Time\"), each issued and outstanding share of common stock of AEON (\"AEON common stock\") was automatically cancelled and converted into approximately 2.328 (the \"Exchange Ratio\") shares of Class A common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents an award of stock options on September 9, 2021, which vests in four yearly installments from March 9, 2021, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":9007,"derivative":{"exercise_price":10,"expiration_date":"2031-09-09","underlying":"Common Stock","underlying_shares":9007},"source":{"system":"sec-edgar","filing":"0001104659-23-083568","document":"tm2321918-11_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1387660/000110465923083568/tm2321918-11_4seq1.xml","form_type":"4"}},{"id":3099598,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":36264,"kind":"person","name":"Carter Eric G","position":1,"cik":"0001387660","reported_name":"Carter Eric G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-25T21:44:15.000Z","date":"2020-06-23","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest on the earlier of June 23, 2021 or the 2021 annual meeting of stockholders, subject to (1) accelerated vesting upon a change of control and (2) the Reporting Person's continued service with the Issuer on the vesting date."}],"balance_after":30000,"derivative":{"exercise_price":25.64,"expiration_date":"2030-06-22","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-20-038958","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1387660/000120919120038958/doc4.xml","form_type":"4"}},{"id":3448807,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":36264,"kind":"person","name":"Carter Eric G","position":1,"cik":"0001387660","reported_name":"Carter Eric G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-02T20:26:05.000Z","date":"2019-07-31","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest on the earlier of (a) the 2020 annual meeting of stockholders and (b) July 31, 2020."}],"balance_after":45000,"derivative":{"exercise_price":13.41,"expiration_date":"2029-07-30","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001209191-19-044256","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1387660/000120919119044256/doc4.xml","form_type":"4"}},{"id":3892153,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":36264,"kind":"person","name":"Carter Eric G","position":1,"cik":"0001387660","reported_name":"Carter Eric G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-15T20:28:40.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest on the one-year anniversary of May 31, 2018."}],"balance_after":35000,"derivative":{"exercise_price":6.25,"expiration_date":"2028-05-30","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-18-038058","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1387660/000120919118038058/doc4.xml","form_type":"4"}},{"id":3957150,"issuer":{"id":154258,"kind":"organization","name":"ALDER BIOPHARMACEUTICALS INC","symbol":"ALDR"},"owners":[{"id":36264,"kind":"person","name":"Carter Eric G","position":1,"cik":"0001387660","reported_name":"Carter Eric G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-04-25T17:27:08.000Z","date":"2018-04-23","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"If the Reporting person remains continuously employed with the Issuer in good standing through the earlier to occur of (i) the twelve (12)-month anniversary of April 23, 2018 and (ii) the date that a new Chief Medical Officer begins employment with the Issuer (such earlier date, the \"End Date\"), 100% of the shares subject to the option will immediately vest on the End Date."}],"balance_after":75000,"derivative":{"exercise_price":13.65,"expiration_date":"2028-04-22","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-18-026121","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423824/000120919118026121/doc4.xml","form_type":"4"}},{"id":4213384,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":36264,"kind":"person","name":"Carter Eric G","position":1,"cik":"0001387660","reported_name":"Carter Eric G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-09-08T22:40:05.000Z","date":"2017-09-07","kind":"grant","acquired":true,"shares":69000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/3 of the total number of shares subject to the option vest and become exercisable on each anniversary of September 7, 2017 (the \"Vesting Commencement Date\"), such that all of the shares subject to the option shall become vested and exercisable as of the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":69000,"derivative":{"exercise_price":2.7,"expiration_date":"2027-09-06","underlying":"Common Stock","underlying_shares":69000},"source":{"system":"sec-edgar","filing":"0001209191-17-052148","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1387660/000120919117052148/doc4.xml","form_type":"4"}},{"id":4213383,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":36264,"kind":"person","name":"Carter Eric G","position":1,"cik":"0001387660","reported_name":"Carter Eric G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-08T22:40:05.000Z","date":"2017-09-07","kind":"grant","acquired":true,"shares":48000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock Units (\"RSUs\"). The Reporting Person is entitled to receive one (1) share of Common Stock of the Issuer for each one (1) RSU upon the vesting thereof. Such RSUs vest with respect to 1/3 of the shares subject thereto on each anniversary of September 7, 2017 (the \"Vesting Commencement Date\"), such that all of the shares subject to the RSUs shall be vested as of the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":48000,"source":{"system":"sec-edgar","filing":"0001209191-17-052148","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1387660/000120919117052148/doc4.xml","form_type":"4"}}]}